Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2387-2394

  Siow, Richard C M ^a,c   Richards, Justin P ^b   Pedley, Kevin C ^a   Leake, David S ^b   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Ascorbic acid; Atherosclerosis; Bcl x(L); Low density lipoprotein; Oxidized; Smooth muscle, vascular

Indexed keywords

ASCORBIC ACID; DNA FRAGMENT; LIPID HYDROPEROXIDE; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN; OXIDOREDUCTASE; PROTEIN BCL X;

APOPTOSIS; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET THERAPY; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VITAMIN SUPPLEMENTATION;

EID: 0032880548     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2387     Document Type: Article

References (50)

1. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
2. Witztum JL, Steinberg D. Role of oxidized low-density-lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
5. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem. 1997;272: 22975-22978.
6. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the 'response to injury' hypothesis. Circulation. 1997;95:1760-1763.
7. Jovinge S, Crisby M, Thyberg J, Nilsson J. DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler Thromb Vasc Biol. 1997;17:2225-2231.
8. Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem. 1998;273:9681-9687.
9. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
10. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
11. Pollman MJ, Hall JL, Mann MJ, Zhang LN, Gibbons GH. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 1998;4:222-227.
12. Thorne SA, Abbot SE, Winyard PG, Blake DR, Mills PG. Extent of oxidative modification of low-density-lipoprotein determines the degree of cytotoxicity to human coronary-artery cells. Heart. 1996;75:11-16.
13. Bjorkerud B, Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 1996;16:416-424.
14. Cox DA, Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev. 1996;48:3-19.
15. Chatterjee S. Role of oxidized human plasma low-density lipoproteins in atherosclerosis: effects on smooth-muscle cell-proliferation. Mol Cell Biochem. 1992;111:143-147.
16. Schmitt A, Salvayre R, Delchambre J, Negre-Salvayre A. Prevention by alpha-tocopherol and rutin of glutathione and ATP depletion induced by oxidized LDL in cultured endothelial cells. Br J Pharmacol. 1995;116: 1985-1990.
17. Auge N, Pieraggi MT, Thiers JC, Negresalvayre A, Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 1995;309:1015-1020.
18. Marchant CE, Law NS, Vanderveen C, Hardwick SJ, Carpenter KLH, Mitchinson MJ. Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. FEBS Lett. 1995;358:175-178.
19. Nishio E, Arimura S, Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Biochem Biophys Res Commun. 1996;223:413-418.
20. Vieira O, Escargueil-Blanc I, Meilhac O, Basile JP, Laranjinha J, Almeida L, Salvayre R, Negre-Salvayre A. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol. 1998;123:565-573.
21. Guyton JR, Lenz ML, Mathews B, Hughes H, Karsan D, Selinger E, Smith CV. Toxicity of oxidized low-density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis. 1995;118:237-249.
22. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113.
23. Vita JA, Keaney JF, Raby KE, Morrow JD, Freedman JE, Lynch S, Koulouris SN, Hankin BR, Frei B. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol. 1998;31:980-986.
24. Siow RCM, Sato H, Bannai S, Leake DS, Pearson JD, Mann GE. Vitamin C protects human arterial smooth muscle cells against atherogenic lipoproteins: effects of antioxidant vitamins on oxidized LDL-induced increases in cystine transport and glutathione. Arterioscler Thromb Vasc Biol. 1998;18:1662-1670.
25. Wilkins GM, Leake DS. The effect of inhibitors of free radical generating-enzymes on low density lipoprotein oxidation by macrophages. Biochim Biophys Acta. 1994;1211:69-78.
26. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
27. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
28. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens GA. Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989;30:627-630.
29. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271-277.
30. Ortiz EM, Dusetti NJ, Vasseur S, Malka D, Bödeker H, Dagorn JC, Iovanna JL. The pancreatitis-associated protein is induced by free radicals in AR4-2J cells and confers cell resistance to apoptosis. Gastroenterology. 1998;114:808-816.
31. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Vanschie RC, LaFace DM, Green DR. Early redistribution of plasma-membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
32. L. J Biol Chem. 1996;271:6306-6312.
33. Carpenter KLH, Wilkins GM, Fussell B, Ballantine JA, Taylor SE, Mitchinson MJ, Leake DS. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. 1994;304:625-633.
34. Mitchinson MJ, Hardwick SJ, Bennett MR. Cell death in atherosclerotic plaques. Curr Opin Lipidol. 1996;7:324-329.
35. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low-density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
36. Rice-Evans CA, Leake DS, Bruckdorfer KR, Diplock AT. Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls. Free Radic Res. 1996;25:285-311.
37. Jessup W, Rankin SM, de Whalley CV, Hoult JRS, Scott J, Leake DS. α-Tocopherol consumption during low density lipoprotein oxidation Biochem J. 1990;265:399-405.
38. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Lipid peroxide and transition metals are required for the toxicity of oxidize low-density lipoprotein to cultured endothelial cells. Biochim Biophys Acta. 1991;1096:155-161.
39. Axelson M, Larsson O. Low density lipoprotein (LDL) cholesterol is converted to 27-hydroxycholesterol in human fibroblasts: evidence that 27-hydroxycholesterol can be an important intracellular mediator between LDL and the suppression of cholesterol production. J Biol Chem. 1995;270:15102-15110.
40. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
41. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low-density lipoprotein in human plasm J Clin Invest. 1996;98:800-814.
42. Chisolm GM, Ma GP, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, Dicorleto PE. 7-Beta-hydroperoxycholest-5-en-3-beta-ol, component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low-density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:11452-11456.
43. Nishio E, Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein down-regulation. Biochem Biophys Res Commun. 1996;226:928-934.
44. Aoshima H, Satoh T, Sakai N, Yamada M, Enokido Y, Ikeuchi T, Hatanaka H. Generation of free radicals during lipid hydroperoxide-triggered apoptosis in PC12h cells. Biochim Biophys Acta. 1997;1345: 35-42.
45. Sandstrom PA, Pardi D, Tebbey PW, Dudek RW, Terrian DM, Folks T, Buttke TM. Lipid hydroperoxide-induced apoptosis: lack of inhibition by Bcl-2 overexpression. FEBS Lett. 1995;365:66-70.
46. Harada K, Ishibashi S, Miyashita T, Osuga J, Yagyu H, Ohashi K, Yazaki Y, Yamada N. Bcl-2 protein inhibits oxysterol-induced apoptosis through suppressing CPP32-mediated pathway. FEBS Lett. 1997;411:63-66.
47. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
48. Haendeler J, Zeiher AM, Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol. 1996;317:407-411.
49. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant atherosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med. 1998;4:1392-1396.
50. Tribble DL. Antioxidant consumption and risk of coronary heart disease emphasis on vitamin C, vitamin E, and β-carotene. Circulation. 1999;99:591-595.